1,1-dicyclopropylprop-2-yn-1-ol | 24297-12-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,1-dicyclopropylprop-2-yn-1-ol
• 英文别名: 1,1-dicylopropylprop-2-yn-1-ol；1,1-dicyclopropyl-2-propyn-1-ol；Ethinyl-dicyclopropylcarbonium；Dicyclopropylaethinylcarbinol
• CAS: 24297-12-9
• 化学式: C₉H₁₂O
• 分子量: 136.194
• InChiKey: OXBOSLIINGKALV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1,1-dicyclopropylprop-2-yn-1-ol 在 偶氮二甲酸二异丙酯 、 2-硝基苯磺酰肼 、 三苯基膦 作用下， 以 四氢呋喃 为溶剂， 生成 3-(1,1-dicyclopropylbuta-2,3-dien-1-yl)-1-methyl-1H-indole
  参考文献：
  名称：

  Regioselective Synthesis of Elusive 4,9-Dihydro-1H-Carbazoles by Gold-Catalyzed Cycloisomerization of 3-Allenylmethylindoles

  摘要：

  A general and efficient synthesis of 4,9-dihydro-1H-carbazoles from 3-allenylmethylindoles is reported. The process, catalyzed by a cationic gold(I) complex, involves a formal C2-H bond activation of the indole unit by reaction with the allene. The nature of the substituents at the allylic and terminal positions of the allene moiety has a crucial effect on the regioselectivity of the cyclization, which is also influenced by the catalyst and the solvent employed. Moreover, some evidence of the contribution of different reaction routes is provided, which led us to propose a plausible multipathway mechanism consistent with all of the results described.

  DOI：

  10.1021/jo401388b
• 作为产物：
  描述：

  1,1-dicyclopropyl-3-(trimethylsilyl)prop-2-yn-1-ol 在 4-乙炔-四氢-2H-吡喃-4-醇 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 1,1-dicyclopropylprop-2-yn-1-ol
  参考文献：
  名称：

  Novel pharmaceutical compounds

  摘要：

  这种瞬间发明提供了化合物I的公式，这些化合物是白三烯生物合成抑制剂。 公式I的化合物可用作抗动脉粥样硬化、抗哮喘、抗过敏、抗炎和细胞保护剂。

  公开号：

  US20080188521A1

文献信息

• [EN] BIS-(SULFONYLAMINO) DERIVATIVES FOR TREATMENT OF PAIN AND INFLAMMATION<br/>[FR] DÉRIVÉS BIS-(SULFONYLAMINO) DESTINÉS AU TRAITEMENT DE LA DOULEUR ET DE L'INFLAMMATION
  申请人：ASTRAZENECA AB

  公开号：WO2010132016A1

  公开（公告）日：2010-11-18

  The invention provides compounds of formula (I) wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

  该发明提供了式（I）的化合物，其中R1、R2、R3、A和m如规范中定义，并且其光学异构体、消旋体和互变异构体，以及其药学上可接受的盐；以及它们的制备方法、含有它们的药物组合物以及它们在治疗中的应用。这些化合物是微粒体前列腺素E合成酶-1的抑制剂。
• Phosphorus-Containing Bis-allenes: Synthesis and Heterocyclization Reactions Mediated by Iodine or Copper Dibromide
  作者：I. Essid、C. Laborde、F. Legros、N. Sevrain、S. Touil、M. Rolland、T. Ayad、J.-N. Volle、J.-L. Pirat、D. Virieux

  DOI：10.1021/acs.orglett.7b00648

  日期：2017.4.7

  Bisphosphorylallenes were easily obtained in multigram scale from the Wittig-type rearrangement of bispropargyl alcohols. Unlike other conjugated bis-allenes, these reagents underwent a double cyclization mediated by iodine or copper dibromide leading to the formation of bis-1,2-oxaphospholenes.

  从双炔丙基醇的Wittig-型重排可容易地以克数获得双磷酸烯丙二酯。与其他共轭双烯丙二烯不同，这些试剂经历了由碘或二溴化铜介导的双环化作用，从而导致了双1,2-氧杂膦烯的形成。
• [EN] DIACYLGLYCEROL KINASE MODULATING COMPOUNDS<br/>[FR] COMPOSÉS MODULANT LA DIACYLGLYCÉROL KINASE
  申请人：CARNA BIOSCIENCES INC

  公开号：WO2021130638A1

  公开（公告）日：2021-07-01

  The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.

  本公开提供了调节二酰基甘油激酶的化合物以及用于治疗癌症（包括实体瘤）和病毒感染（如HIV或乙型肝炎病毒感染）的药物组合物。这些化合物可以单独使用或与其他药物联合使用。
• Photochromic spiropyran compounds
  申请人：PPG Industries, Inc.

  公开号：US04931221A1

  公开（公告）日：1990-06-05

  Described are a series of novel photochromic benzopyran and naphthopyran compounds in which two cyclopropyl groups are appended at the 2-position of the benzopyran or naphthopyran ring. Also described are organic host materials that contain or that are coated with such compounds. Articles such as ophthalmic or plano lenses that incorporate the noval pyran compounds or combinations of the novel pyran compounds with other complementary photochromic compounds are described. ##STR1##

  本文介绍了一系列新型光致变色苯并吡喃和萘并吡喃化合物，其中在苯并吡喃或萘并吡喃环的2位上附有两个环丙基基团。本文还介绍了含有这种化合物或被这种化合物涂覆的有机宿主材料。本文还描述了包含新型吡喃化合物或新型吡喃化合物与其他互补光致变色化合物组合的眼科或平面镜片等物品。 ##STR1##
• Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
  申请人：Merck Sharp & Dohme Corp.

  公开号：US07960409B2

  公开（公告）日：2011-06-14

  The instant invention provides compounds of Formula I which are leukotriene biosynthesis inhibitors. Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.

  本发明提供了I式化合物，它们是白三烯生物合成抑制剂。I式化合物可用作抗动脉粥样硬化、抗哮喘、抗过敏、抗炎和细胞保护剂。

表征谱图